logo
Impact Radar
  • Overview
  • Impact Performance
  • Compare this company
  • All sources
    • Sign UpLog In
    logo

    Ionis Pharmaceuticals | Sustainability & Chart

    US4622221004

    Basic information on Ionis Pharmaceuticals

    Location: United States

    Industry: Health Services

    Website

    knob-globe
    60%

    Impact Score

    Description Ionis Pharmaceuticals

    Ionis Pharmaceuticals Inc. is a biopharmaceutical company that specializes in discovering and developing RNA-targeted therapeutics for patients with serious diseases.

    Ionis Pharmaceuticals Sustainability Performance

    Renewable Energy
    Greenhouse Gas Emissions
    Supply Chain
    Waste Recycling
    Sustainable [100]
    Almost sustainable [67-99]
    Moderate [34-66]
    Not sustainable [0-33]
    No data
    We measure the sustainability of companies based on 12 criteria.Indicators range from 0 to 100: values from 0 to 33 are shown in red (“not sustainable”), values from 34 to 66 in yellow (“moderate”), values from 67 to 99 in light green (“almost sustainable”), and a value of 100 in green (“sustainable”). Learn more about our method.

    Compare Ionis Pharmaceuticals with ...

    Ionis Pharmaceuticals

    ?

    Impact Score

    knob-globe
    60%
    knob-globe
    0%
    Climate
    Society
    Gender

    Sources of sustainability performance

    MetricValueUnitYearPDF NamePDF Page
    Employee turnover rate
    Employee turnover5,7%20242024-Corporate-Responsiblity-Report.pdf43
    Gender Pay Gap
    Adjusted gender pay gap0%2024IONIS PHARMACEUTICALS, INC._10K_2025_covers.pdf39
    Glass Ceiling
    Women in workforce56,7%20242024-Corporate-Responsiblity-Report.pdf38
    Women in management48,1%20242024-Corporate-Responsiblity-Report.pdf38
    Greenhouse Gas Emissions
    Scope 1 emissions2 616Metric tons CO2e20242024-Corporate-Responsiblity-Report.pdf39
    Scope 2 emissions, market based2 530Metric tons CO2e20242024-Corporate-Responsiblity-Report.pdf39
    Number of employees1 056Total20242024-Corporate-Responsiblity-Report.pdf38
    Harassment and Discrimination at the Workplace
    Anti-discrimination policyYes20242024-Corporate-Responsiblity-Report.pdf24
    Confidentiality mechanismsYes2024Code of Ethics and Business Conduct_Approved June 5 2024.pdf8
    Incident notification mechanismYes20242024-Corporate-Responsiblity-Report.pdf34
    Retaliation safeguardsYes2024Code of Ethics and Business Conduct_Approved June 5 2024.pdf9
    Renewable Energy
    Total energy consumption12 038(MWh)20242024-Corporate-Responsiblity-Report.pdf39
    Total renewable energy consumption4 875(MWh)20242024-Corporate-Responsiblity-Report.pdf39
    Union Formation and Collective Bargaining Power
    Collective bargaining agreements coverage0%2024IONIS PHARMACEUTICALS, INC._10K_2025_covers.pdf38
    Recycling and Recovery of Waste
    Waste recycled60Tons20242024-Corporate-Responsiblity-Report.pdf39
    Total waste generation293Tons20242024-Corporate-Responsiblity-Report.pdf39
    Women on the Board
    Women on supervisory board3directors20242024-Corporate-Responsiblity-Report.pdf33
    Supervisory board size10directors20242024-Corporate-Responsiblity-Report.pdf33
    Women on executive board2Officers2024IONIS PHARMACEUTICALS, INC._10K_2025_covers.pdf40
    Executive board size11Officers2024IONIS PHARMACEUTICALS, INC._10K_2025_covers.pdf40
    Women in Management
    Women in management48,1%20242024-Corporate-Responsiblity-Report.pdf38
    Note: The PDF pages given here refer to the page in the PDF document, which is not necessarily the one found in the footer of the page. For example, page 10 is the 10th page in the document, even if it is labeled as page 8.

    Find more sustainable companies

    logo
    HomeFind Companies & ETFsLearn to investAcademyGlossaryOur Method
    ImprintPrivacy PolicyGTCFAQContact Us
    © 2025 money:care GmbHDisclaimerThe information provided is for informational purposes only and does not constitute an offer, recommendation, or investment advice to buy or sell financial instruments. Nor may they or any part of them be used as a basis for concluding a contract. They have been adopted in good faith from publicly accessible sources. No liability can be assumed for their accuracy. Any financial instrument referred to in this information and documents may be unsuitable for the respective investor to whom it is addressed. The recipients of such information and documents are responsible for independently evaluating and reviewing the products, assets, and financial instruments mentioned therein. Investors must make their own assessment of the suitability of the financial instruments mentioned herein based on the benefits and risks associated with the acquisition of the products, as well as on the basis of their own investment strategy and their legal, tax, and financial situation. Should readers use the content offered or follow any advice, they act on their own responsibility.The source of ETF data is the websites and data sheets of the respective ETF providers.Logos provided by Clearbit (https://clearbit.com/). All trademarks and logos appearing on this website are the property of their respective owners and are used here for informational and educational purposes only, under fair use guidelines. We claim no affiliation with, nor endorsement by, the companies whose trademarks and logos are displayed. This website is independent of the brands analyzed and receives no direct or indirect compensation from them.The information contained in the company descriptions is generated by artificial intelligence and is for informational purposes only. While we strive for accuracy, the content may not be entirely reliable or comprehensive. We recommend cross-referencing the AI-generated content with other reliable sources to verify it and gain a more comprehensive understanding of the respective companies.Some links are affiliate links. If you click on these links and open an account, we will receive a small commission. Don't worry, you won't incur any additional costs. Thank you for your support!